Skip to main content
Retour
CAPR logo

Capricor Therapeutics, Inc.

Qualité des données : 100%
CAPR
NASDAQ Healthcare Biotechnology
30,10 €
▲ 1,00 € (3,44%)
Cap. Boursière : 1,38B
Fourchette du Jour
28,15 € 30,32 €
Fourchette 52 Semaines
4,30 € 40,37 €
Volume
1 311 263
Moyenne 50J / 200J
26,28 € / 14,68 €
Clôture Précédente
29,10 €

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Healthcare (626 pairs)

Métrique Action Médiane du Secteur
P/E -13,1 0,4
P/B 4,5 2,9
ROE % -46,6 3,8
Net Margin % 3,9
Rev Growth 5Y % 10,0
D/E 0,1 0,2

Points Clés

Debt/Equity of 0,07 — conservative balance sheet
Negative free cash flow of -72,72B

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)-100,00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-46,56%
ROIC-24,82%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
0,07
Current Ratio9,01
Interest Coverage-35,51

Valorisation

P/E Ratio
-13,10
P/B Ratio4,50
EV/EBITDAN/A
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) -100,00% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0,0 Net Income (TTM) -105,04M
ROE -46,56% ROA -29,51%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -72,72B
ROIC -24,82% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,07 Current Ratio 9,01
Interest Coverage -35,51 Dividend Yield 0,00%
Valuation
P/E Ratio -13,10 P/B Ratio 4,50
P/S Ratio N/A PEG Ratio -0,13
EV/EBITDA N/A Dividend Yield 0,00%
Market Cap 1,38B Enterprise Value 1,11B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0,0 22,27M 25,18M 2,55M 244 898,0
Net Income -105,04M -40,47M -22,29M -29,02M -20,02M
EPS (Diluted) -2,26 -1,15 -0,83 -1,18 -0,87
Gross Profit 0,0 -27,70M -11,27M -19,27M 244 898,0
Operating Income -108,14M -42,56M -24,08M -29,70M -20,94M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 355,95M 170,48M 58,73M 50,09M 41,33M
Total Liabilities 50,16M 25,02M 36,13M 38,31M 9,96M
Shareholders' Equity 305,79M 145,46M 22,60M 11,79M 31,37M
Total Debt 20,94M 1,45M 2,24M 2,56M 2,87M
Cash & Equivalents 287,85M 11,29M 14,69M 9,60M 34,89M
Current Assets 322,94M 163,39M 50,86M 42,89M 36,44M
Current Liabilities 35,84M 21,03M 31,27M 23,59M 4,13M